Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950138-19-000343
Filing Date
2019-06-07
Accepted
2019-06-07 16:12:22
Documents
1
Period of Report
2019-06-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3017
  Complete submission text file 0000950138-19-000343.txt   4409
Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address
Reasons Bryan M. (Reporting) CIK: 0001553489 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 19885847

Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1227
SIC: 2834 Pharmaceutical Preparations